Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Inventory Average (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Inventory Average data on record, last reported at $188.8 million in Q3 2025.

  • For Q3 2025, Inventory Average rose 49.44% year-over-year to $188.8 million; the TTM value through Sep 2025 reached $188.8 million, up 49.44%, while the annual FY2024 figure was $129.8 million, 23.95% up from the prior year.
  • Inventory Average reached $188.8 million in Q3 2025 per AMPH's latest filing, roughly flat from $188.6 million in the prior quarter.
  • Across five years, Inventory Average topped out at $188.8 million in Q3 2025 and bottomed at $94.0 million in Q1 2022.
  • Average Inventory Average over 5 years is $118.6 million, with a median of $104.1 million recorded in 2023.
  • Peak YoY movement for Inventory Average: dropped 11.2% in 2021, then surged 58.55% in 2025.
  • A 5-year view of Inventory Average shows it stood at $96.5 million in 2021, then rose by 7.14% to $103.4 million in 2022, then grew by 4.34% to $107.9 million in 2023, then soared by 31.62% to $142.0 million in 2024, then skyrocketed by 32.95% to $188.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $188.8 million in Q3 2025, $188.6 million in Q2 2025, and $169.6 million in Q1 2025.